NEOFORMA gestern + 23,08 % in USA !!!! - 500 Beiträge pro Seite

[moreinput]

Morgen kommen die Quartalszahlen - Infos unter:

http://www.stockpoint.com/quote.asp?Exchange=US&Symbol=neof&…

....Sie musste ja irgendwann abgehen!!!!

[belbo]

wann kommen denn nun diezahlen???
das ist ja das reinste ratespiel - jeder nennt einen anderen termin...
:-(
b.

[moreinput]

Auszug aus der oben genannten Mitteilung:

The conference call will take place on Thursday, October 19, 2000 at 10 AM Eastern Daylight Time (7 AM Pacific Daylight Time). To access the call via the Web, please visit http://www.neoforma.com.

[Nebelwandraser]

Die Daten erscheinen definitiv morgen am 19.10!
Live übers Internet... Wenn die so ein Tamtam machen sind die Zahlen vielleicht nicht übel , hehehe!
Der starke Kursanstieg gegen die allgemeine Lage an der NASDAQ verspricht ebenfalls einiges.

Viele Grüsse an alle anderen Neof-Anhänger; ich glaub die dürren Zeiten sind vorbei !!!

Neoforma to Release Third Quarter Financial Results

SAN JOSE, Calif.--(BW HealthWire)--Oct. 17, 2000--Neoforma.com, Inc. (Nasdaq:NEOF), a leading provider of e-commerce solutions
to healthcare, announced today that it intends to release its financial results for the third quarter ending September 30, 2000, on Thursday,
October 19, 2000.

In conjunction with this release, Neoforma will host a conference call, which will be simultaneously broadcast live over the Internet on
Neoforma`s Web site. Bob Zollars, chairman, president and chief executive officer of Neoforma, and Fred Ruegsegger, Neoforma`s chief
financial officer, will host the call. Topics discussed on the call will include the company`s third quarter financial results, the status of
Neoforma`s business and its outlook for future periods.

The conference call will take place on Thursday, October 19, 2000 at 10 AM Eastern Daylight Time (7 AM Pacific Daylight Time). To
access the call via the Web, please visit http://www.neoforma.com.

Interested parties should allow extra time prior to the call to visit the site and download the streaming media software required to listen to
the Internet broadcast. The online audio archive of the broadcast will be available after the live call and will remain available on the site
for one week.

About Neoforma.com, Inc.


Neoforma.com, Inc., is a leading provider of business-to-business e-commerce solutions to the global medical marketplace. Focused on
transforming the inefficient and highly fragmented healthcare supply chain, the company provides online solutions that enable buyers to
lower product-procurement costs, while giving suppliers a new, highly efficient direct marketing channel. Neoforma is building multiple
custom marketplaces to meet the needs of leading healthcare organizations such as the members of VHA and UHC. Neoforma`s
comprehensive e-commerce solutions are focused on improving the process of healthcare purchasing, from planning to procurement to
liquidation. For more information, visit the company`s Web site at www.neoforma.com.

Note to Editors: Neoforma.com, Inc., and www.neoforma.com are trademarks of Neoforma.com, Inc. Other Neoforma.com logos,
product names, and service names are also trademarks of Neoforma.com, Inc., which may be registered in other countries. Other product
and brand names are trademarks of their respective owners.

CONTACT: Neoforma.com, Inc., San Jose
Isabelle Trempe, 408/468-4240
[e-mail]

[RudiDutschke]

Zahlen am 19-10 um 10.00h a.m. easterm time
Quelle: homepage

[belbo]

na denn lassen wir uns mal überraschen - wird schon werden...
b.

[garoto]

Der heutige Kurseinbruch an der Nasdaq geht NEOFORMA am A.sch vorbei!

[schluriffm]

huiiiiiiiiiiii

und schon wieder 7,5 % im plus in amiland s.u.
heute nochmal + 20 %
schade wegen des schlechten marktumfelds!!


NEOFORMA.COM INC - Nasdaq National Market: NEOF

Last Change (%) Bid (size) Tick Ask (size) Trade Time
2 11/16 3/16 (7.50) 2 5/8 (40) + 2 11/16 (10) 10:35
Day Volume Last Size Open High Low
48,700 600 2 7/16 2 11/16 2 5/16
Latest Ticks # of Trades Avg Trade Size 52 Wk High 52 Wk Low
+-++ 70 696 78 3/4 2
Prev Close VWAP UPC
2 1/2 2 1/2


gruss

[garoto]

... und schon 10% plus!

[garoto]

... und schon sind´s + 12,5%, warten wir es ab....

[garoto]

und 3$ = +20%

[Thoemsi]

Hey garoto,
das wollt ich gerade posten:
3$;+20%

...ist das schön, wieder in der Gewinnzone zu sein...

[moreinput]

Blödsinn!!!!

+ 25 % !!!!!!!

;-)

[schluriffm]

quatsch jetzt 36,25 % in amiland

)))))))))))))))))

gruss

[Thoemsi]

...das Teil geht wie von einer riesen Faust geschoben....



waren grad schon auf 3,5$, jetzt wieder auf 3,25$
-> + 30%

heute müssen wir uns anschnallen.....

[garoto]

Hä!? woher hast du 36,25%? Sind "nuuuuuuuuuuuuuur" 30% oder?

[garoto]

o mein Gott sind schon 40%, würg.......

[Thoemsi]

jetzt "nur" noch bei +17,5%

Aber sie sind schon wieder höhergestellt..
..nur die deutschen Börsen scheinen von den 3,5$ nix mitgekriegt zu
haben..da blieb der Kurs nämlich auf 3,5€ stehen.(fair wären 4,15€
gewesen)

[Thoemsi]

na also...
jetzt + 21,25%

[garoto]

ich weiß nicht woher Ihr eure Zahlen habt, bei mir sinds immer noch + 30% ist 3,25US$, entspricht in etwa 3,8 Euro. Fft steht auf Geld 3,6 und Brief 3,9 Euro.

[Thoemsi]

http://quotes.freerealtime.com/rt/frt/N?IM=quotes&symbol=NEO…

www.freerealtime.com

lass dich dort kostenlos registrieren, dann hast du unbegrenzte Realtimekurse für die USA

[garoto]

Danke Thoemsi!

[studilu]

hallo leute,
bin schon seit 2.80 usd wieder in der gewinnzone
da neof für mich ein zockerpapier, gebe ich wahrscheinlich einen teil bei ca. 4 usd ab.
mein geschätztes kursziel heute bei schluss von 2.90 wird übertroffen.
nächstes kursziel, je nach q-zahlen bis ende oktober 4 - 6 usd.

auf gute geschäfte
ciao stu :O

[2505]

@stdilu
Du wirst noch übertroffen, aktuell +20% 3,00$
es liegt eine ganze Flotte von Kauforders im Pipeline!!!!!!

[RudiDutschke]

aktuell bei 2,5$
hoffe auf einen Endspurt

[RudiDutschke]

Neoforma Zahlen für das 3. Quartal:
net loss $47,5 gegenüber $59,6 2. Quartal
je Aktie $0,46 gegenüber $ 1,02 2. Quartal
net revenues $2,3Mio.
gross transactions $22,7Mio.
3. Quartal=Rekordergebnis
Quelle: www.stockpoint.com unter news Neof eingeben.

[Nebelwandraser]

Die Zahlen sind gut !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Neoforma Reports Record Third Quarter Revenues; Significant Momentum at Marketplace@Novation

SAN JOSE, Calif.--(BW HealthWire)--Oct. 18, 2000--Neoforma.com, Inc. (Nasdaq:NEOF), a leading provider of business-to-business
e-commerce solutions to the global medical marketplace, today announced its financial results for the third quarter ended September 30,
2000.

For the third quarter, net revenues were $2.3 million, comprised primarily of transaction fees paid in connection with the use of the
company`s "Shop" service and live and online "Auction" services, professional service fees earned by the company`s "Services Delivery"
organization, and subscription and license fees for "Plan" services and software. The gross value of transactions on which the company
earned revenues for the third quarter was approximately $22.7 million. Third quarter gross transactions and net revenues represent record
highs for the company.

Total cash operating expenses for the third quarter were $20.3 million, lower than anticipated. Total non-cash operating expenses for the
same period were $30.2 million, lower than expected as a result of reduced charges related to the stock issued to VHA and UHC. The
net loss for the quarter was $47.5 million, or $0.46 per share, compared to a net loss of $59.6 million, or $1.02 per share, for the second
quarter of 2000. Excluding all non-cash and non-recurring charges for the periods, the net loss for the third quarter was $17.3 million, or
$0.17 per share, compared to $18.7 million, or $0.32 per share, for the second quarter.

The third quarter results represent an increase in gross value of transactions and net revenues of approximately 40% and 12%
respectively, compared to the second quarter of 2000. The following table sets forth the company`s gross transactions and net revenues by
service line for the third quarter (amounts in thousands):

Service Line Gross Transactions Net Revenues

Shop(1) $18,581 $753
Auction 3,088 510
Plan 581 581
Services Delivery 485 485
--- ---
$22,735 $2,329

(1) Shop net revenues include $255,000 in Novation catalog set-up
fees.

As of September 30, 2000, cash, cash equivalents and short and long-term investments totaled $52.5 million.

"We made solid progress in our business and achieved a number of milestones during the third quarter, including significantly increasing
Shop transaction fees by 54% from the second quarter," commented Bob Zollars, chairman, president and chief executive officer of
Neoforma. "One of the strengths of our business model is the generation of revenue from multiple sources. In addition, our ongoing focus
on reducing costs resulted in cash operating expense reductions that exceeded our expectations."

In a separate press release issued today, Neoforma discussed its progress in building Marketplace@Novation, including a significant
number of additional hospital and supplier sign-ups, as well as implementations on the first wave of hospitals. "The combination of
increased revenues and reduced expenses, as well as the progress in attracting buyers and suppliers to our marketplace, demonstrates the
company`s focus and solid execution," commented Zollars.

In the third quarter, the Auction business generated significant revenues from liquidation sales resulting from hospital closures. Unlike
traditional Auction revenues, which are primarily commissions received on the sales of consigned equipment, liquidation revenues are
generated on sales where Neoforma has taken title to the equipment. Consequently, Neoforma will display gross revenues on such sales in
the revenue section of the income statement, with the related cost of used equipment being shown in the operating expense section of the
income statement, commencing this quarter.

Separately, the company also announced that Andrew Guggenhime has been appointed chief financial officer. Mr. Guggenhime, currently
vice president of corporate development, previously led the company`s successful initial public offering as vice president for the company`s
lead underwriter, Merrill Lynch. Mr. Guggenhime replaces Frederick Ruegsegger as chief financial officer, who stepped down to pursue
other opportunities. "While we wish Fred well as he pursues new opportunities, we are exceptionally pleased to have someone as capable
as Andrew assume the responsibilities of CFO for Neoforma," commented Bob Zollars. "The combination of Andrew`s background and
his current responsibilities at Neoforma will ensure a smooth transition for the company," continued Zollars. The change will be effective
immediately.

About Neoforma.com, Inc.


Neoforma is a leading provider of business-to-business e-commerce solutions to the global medical marketplace. Focused on transforming
the inefficient and highly fragmented healthcare supply chain, the company provides an open, online marketplace that enables buyers to
lower product-procurement costs, while giving suppliers a new, highly efficient direct marketing channel. Neoforma`s comprehensive
e-commerce solutions are focused on improving healthcare purchasing needs, from planning to procurement to liquidation. For more
information, visit the company`s Web site at www.neoforma.com.

This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E
of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those sections. These forward-looking statements
include statements related to future growth and revenues, reduction of expenses, growth of Marketplace@Novation, and increases in
transaction volumes and in buyers and suppliers using its marketplaces. These forward-looking statements involve a number of risks and
uncertainties that could cause actual results to differ materially from those anticipated by these forward-looking statements. These risks
include the risk that the company may be unable to increase its transaction volumes, to attract and retain a broad range of purchasers and
suppliers, to successfully integrate the operations of acquired companies and to increase operating efficiencies. These and other risks are
discussed in the company`s most recent Form 10-K and Form 10-Q filings with the Securities and Exchange Commission. These risks and
other risks are described in Neoforma`s periodic reports filed with the SEC including its recent Form 10-K. Neoforma assumes no
obligation to update the forward-looking information contained in this news release.

Note to Editors: Neoforma.com, Inc., and www.neoforma.com are trademarks of Neoforma.com, Inc. Other Neoforma.com logos,
product names, and service names are also trademarks of Neoforma.com, Inc., which may be registered in other countries. Other product
and brand names are trademarks of their respective owners.

Neoforma.com, Inc.
Consolidated Statements of Operations
(in thousands, except per share amounts)

For the Quarters Ended For the Nine Months Ended
September 30, September 30,
1999 2000 1999 2000

NET REVENUE:
Shop $ -- $ 753 $ -- $ 1,213
Auction -- -- -- --
Sales of
used equipment -- 2,738 -- 3,306
Cost of
used equipment -- (2,398) -- (2,562)
Transaction fees
on consigned
equipment
& other 451 170 451 1,067

Total Auction
net revenue 451 510 451 1,811

Plan 6 581 13 1,644
Services -- 485 -- 943

Total net
revenue 457 2,329 464 5,611

OPERATING
EXPENSES:
Cost of services -- 2,137 -- 2,796
Operations 1,049 2,735 2,328 7,829
Product
development 1,693 5,625 4,183 14,886
Selling and
marketing 2,659 7,346 4,971 28,001
General and
administrative 4,185 2,412 5,729 8,622
Depreciation and
amortization 412 10,362 647 23,396
Amortization
of deferred
compensation 5,662 7,889 5,662 27,368
Amortization
of partnership
costs -- 10,847 -- 10,847
Amortization
of partnership
warrant
valuation -- 1,111 -- 1,111
Cost of warrant
issued to
recruiter 2,057 -- 2,364 --
Write off of
acquired
in-process
research and
development -- -- -- 18,000
Abandoned
acquisition
costs -- -- -- 2,742
Restructuring -- -- -- 2,100

Total operating
expenses 17,717 50,464 25,884 147,698

Loss from
operations (17,260) (48,135) (25,420) (142,087)

OTHER INCOME
(EXPENSE):
Interest income 45 938 173 3,904
Interest expense (242) (345) (337) (896)
Other income
(expense) (30) 21 (30) 21

Net loss $ (17,487) $ (47,521) $ (25,614) $(139,058)

NET LOSS
PER SHARE
Basic and
diluted $ (5.22) $ (0.46) $ (14.20) $ (2.05)

Weighted average
shares -- basic
and diluted 3,353 103,919 1,804 67,886

PRO FORMA NET
LOSS PER SHARE
Basic and
diluted $ (0.57) $ (0.46) $ (0.94) $ (1.95)

Weighted-average
shares -- basic
and diluted 30,474 103,919 27,225 71,402

PRO FORMA NET
LOSS PER SHARE
EXCLUDING
NON-CASH AND
NON-RECURRING
CHARGES(2)
Basic and
diluted $ (0.31) $ (0.17) $ (0.62) $ (0.75)

Weighted-average
shares -- basic
and diluted 30,474 103,919 27,225 71,402

(2) Pro forma net loss per share excluding non-cash and
non-recurring charges specifically excludes depreciation and
amortization, amortization of deferred compensation, partnership costs
and partnership warrant valuation, as well as cost of warrants issued
to recruiters, write off of acquired in-process research and
development, abandoned acquisition costs, and restructuring.

Neoforma.com, Inc.
Consolidated Balance Sheets
(in thousands)

Dec. 31, 1999 Sept. 30, 2000

Cash, cash equivalents
and investments $ 46,775 $ 52,481
Working capital 36,888 30,295
Total assets 77,369 551,957
Notes payable, less current portion 7,743 7,718
Mandatorily redeemable
convertible preferred stock 88,812 --
Total stockholders` equity (deficit) (31,863) 517,472


CONTACT: Neoforma.com
Isabelle Trempe, 408/468-4240
[e-mail]

[RudiDutschke]

@Nebel...
Vielen Dank fürs Reinstellen des gesamten Artikels.

[Gricko]

So weit so gut mit den Zahlen fürs 3 Quartal, aber was können wir jetzt vom Kurs erwarten? Ich bitte um eure Meinungen, nur ernstgemeinte, bitte!

[studilu]

danke ebenfalls !!!
zahlen sehr interessant.
kurs in usa dürfte heute kräftig anziehen
bis jetzt hier jedoch praktisch kein umsatz, schlafen denn noch alle?

ciao stu

[Nebelwandraser]

Hi Leute !

Zu den Zahlen: Die Analystenmeinungen lagen bei einem Verlust von 0,19 USD pro Aktie. NEOF
kam in diesem Quartal auf - 17 USD, übertrifft also die Erwartungen. Meine Infos hab ich von earnings.com.
Wenn ihr anderer Meinung seit postet bitte...

Der Grund für den Kursrückgang in Deutschland liegt einfach darin, daß wir uns dem Schlußstand der Nassie gestern
anpassen. Einen Ausbruch bei uns wird es ohne die USA nicht geben. Heute mittag könnten bei geeignetem Umfeld
die 3.5 USD von gestern leicht fallen. (Nachkaufen ???)
Auch langfristig seh ich für die Aktie positiv. Auf NASDAQ.com steht ein
weiterer positiver Artikel, den ich hier nicht eingefügt hatte. So konnte NEOF doppelt soviele Hospitale für dieses Jahr
verpflichten wie angenommen. Für genauere Infos einfach mal bei Neoforma.com heut um 16.00 Uhr im Live-Chat rein-
schauen. Langfristig dürfte bei gutem Umfeld ein Kurs von 16 USD wieder realistisch sein.

Unser Glück dürften weiterhin die guten Zahlen von Microsoft, AOL, SAP etc. sein.

Grüsse NWR

[RudiDutschke]

@Nebel
wo hast du das mit den Analystenschätzungen her?
bei geschätzten $0,19, und realen $0,46 Verlust sehe ich keine
Übertreffung der Erwartungen. Bitte um Erklärung.

[garoto]

Neoforma Announces Significant Progress in Building Marketplace@Novation; Neoforma and VHA Reaffirm and Restructure Stock Incentive Program

SAN JOSE, Calif. & IRVING, Texas--(BW HealthWire)--Oct. 18, 2000-- Neoforma.com, Inc. (Nasdaq:NEOF) and Novation announced today significant progress in delivering Neoforma`s e-commerce solution to the acute care market in the following areas:

-- Hospital sign-ups

-- Hospital implementations

-- Manufacturer and distributor sign-ups

Neoforma also announced that it has modified its stock incentive program with VHA Inc.

Hospital Sign-ups

As of October 17, 2000, Neoforma has signed contracts with 159 hospitals to conduct business through Marketplace@Novation(TM), the Internet marketplace that Neoforma has built exclusively for Novation. This figure more than doubles Neoforma`s original goal to have 56 hospitals signed by year end, and represents the signing of 80 additional hospitals since September 7, 2000.

"The rate at which these first 159 hospitals have aligned themselves with Marketplace@Novation has greatly exceeded our expectations," commented Bob Zollars, chairman, president and chief executive officer of Neoforma. "We are extremely pleased to have attracted these market-leading hospitals that recognize the significant benefits of our e-commerce solution so early in our sign-up efforts. We now expect to have approximately 200 hospitals signed by year end, well in excess of our original goal of 56 hospitals."

The 159 signed hospitals represent more than $4 billion in annual supply purchases, and each has committed to transact a minimum of 50 percent of its annual purchases through Marketplace@Novation. The hospitals consist of 133 members of VHA Inc., 25 members of the University HealthSystem Consortium (UHC) and one member of HealthCare Purchasing Partners International(TM).

Hospital Implementations

Leveraging its innovative and aggressive implementation methodology, Neoforma is in active implementation in 60 of the signed Marketplace@Novation hospitals. Six of these VHA and UHC hospitals have been connected on budget and ahead of schedule, providing end-to-end connectivity with their key supplier partners.

"Our first hospitals are online ahead of schedule," stated Zollars, "and we remain on track to implement 56 hospitals by the end of the year. Extensive collaboration between the teams at Neoforma, Novation, and the member hospitals has made it possible to implement these first hospitals in such a timely manner, and we look forward to working closely with these key hospital partners and their suppliers to deliver the benefits of our e-commerce solution."

Manufacturer and Distributor Sign-ups

Neoforma and Novation have also signed up 33 additional manufacturers and distributors to Marketplace@Novation, significantly augmenting Neoforma`s existing supplier base. Under the terms of the agreements, these industry leaders -- including Dade Behring, Owens & Minor, Boise Cascade, Medical Action Industries and The Burrows Company -- will connect their information systems to Marketplace@Novation in order to sell their products. These 33 manufacturers and distributors represent more than $2 billion in annual sales to VHA and UHC members.

Through Marketplace@Novation, suppliers will be able to quickly access real-time supply chain data and use that information to drive down process costs for all participants.

"We are pleased that these manufacturers and distributors have made Marketplace@Novation a business priority," commented Mark McKenna, president of Novation. "By signing early, suppliers can anticipate that their products and services will be available as hospitals begin their procurement activity on our online marketplace."

"Novation has made it a priority to continue to sign leading suppliers to our marketplace," McKenna continued. "As proof of our commitment, effective October 1, 2000, we have made provisions for new contracts with manufacturers and distributors to include participation in Marketplace@Novation."

"Our partnership with Neoforma and Novation is a powerful example of how Dade Behring is leveraging the Internet to build stronger relationships with customers," said Jim Reid-Anderson, chief executive officer of Dade Behring, one of the world`s largest clinical diagnostics companies. "We are aggressively moving forward with our e-commerce strategy to give our customers easy access to our products and a better system to manage and lower costs. By participating in Marketplace@Novation, we hope to help hospitals and laboratories work more efficiently and save money, ultimately benefiting patients as well."

"We are pleased to expand our current relationship with Neoforma to include our wide selection of acute products, in addition to the non-acute products that are now available on the site," commented G. Gilmer Minor, III, chairman and chief executive officer of Owens & Minor, the largest medical/surgical supply partner for Novation. "Joining Marketplace@Novation is an important step in serving our VHA and UHC customers."

VHA Stock Incentive Program Modification

In a separate action, Neoforma also announced that it has amended its stock incentive program with VHA in order to provide VHA with greater flexibility to use Neoforma stock as an incentive for VHA`s healthcare organizations to adopt and utilize Marketplace@Novation.

The amendment provides for the substitution of the warrant previously issued to VHA to purchase up to 30,845,020 shares of Neoforma common stock with 30,845,020 shares of restricted Neoforma common stock. These restricted shares will be subject to forfeiture by VHA if substantive performance targets based upon the purchasing volume of VHA healthcare organizations that agree to use Marketplace@Novation are not met. The restricted stock performance targets are identical to those contained in the cancelled warrant.

The use of restricted stock rather than the warrant will remove certain legal limitations inherent in the warrant structure without changing the substance of the performance targets, providing VHA with an increased ability to use Neoforma stock to provide incentives to VHA healthcare organizations to drive business to Marketplace@Novation. Similar to the accounting treatment of the cancelled warrant, the shares of restricted common stock will not be included in the calculation of Neoforma`s shares outstanding for purposes of calculating earnings per share until such shares vest and are no longer subject to forfeiture.

Under the amendment, VHA`s agreement to vote its shares of Neoforma stock in excess of 19.9% of Neoforma`s shares outstanding in the same proportion as the votes cast by all other stockholders, subject to certain exceptions, will continue, and will also cover the shares of restricted common stock issued in substitution for the warrant.

About Neoforma.com, Inc.

Neoforma.com, Inc., is a leading provider of business-to-business e-commerce solutions to the global medical marketplace. Focused on transforming the inefficient and highly fragmented healthcare supply chain, the company provides online solutions that enable buyers to lower product-procurement costs, while giving suppliers a new, highly efficient direct marketing channel. Neoforma is building multiple custom marketplaces to meet the needs of leading healthcare organizations such as the members of VHA and UHC. Neoforma`s comprehensive e-commerce solutions are focused on improving the process of healthcare purchasing, from planning to procurement to liquidation. For more information, visit the company`s Web site at www.neoforma.com.

About Novation

Novation is the supply company of VHA Inc. and the University HealthSystem Consortium, two national healthcare alliances. Based in Irving, Texas, Novation serves the purchasing needs of more than 2,000 members and affiliates of VHA and UHC, as well as more than 5,200 members of HealthCare Purchasing Partners International (HPPI). The largest supply cost management company in healthcare, Novation manages $15 billion in annual purchases for VHA, UHC and HPPI members. For more information on Novation, go to www.novationco.com.

About VHA Inc.

VHA is a nationwide network of 2,000 leading community-owned healthcare organizations and their affiliated physicians. The VHA alliance comprises 27 percent of the nation`s community hospitals, including many of the nation`s largest and most respected institutions. VHA offers programs and services to improve financial and clinical performance, and as a cooperative distributes income annually to members based on their participation. In December 1999, VHA was named one of the "100 Best Companies to Work For" by Fortune magazine. For more information on VHA, go to www.VHA.com.

About University HealthSystem Consortium

University HealthSystem Consortium (UHC), based in Oak Brook, IL, is an alliance of 82 academic medical centers and 78 associate members. UHC represents approximately 70 percent of the academic medical centers in the United States. For more information on UHC, go to www.uhc.edu.

This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those sections. These forward-looking statements include statements related to the anticipated benefits of Neoforma`s agreements with the healthcare organizations, suppliers, distributors and VHA. There are a number of technological and business risks that could cause actual results to differ materially from those anticipated by these forward-looking statements. These risks and other risks are described in Neoforma.com`s periodic reports filed with the SEC including its Form 10-K for the year ended December 31, 1999, its Form 10-Q for the quarter ended June 30, 2000 and its Proxy Statement, dated June 29, 2000, relating to the VHA and UHC transactions. Neoforma.com assumes no obligation to update the forward-looking information contained in this news release.

Note to Editors: Neoforma.com, Inc., and www.neoforma.com are trademarks of Neoforma.com, Inc. Other Neoforma.com logos, product names, and service names are also trademarks of Neoforma.com, Inc., which may be registered in other countries. Other product and brand names are trademarks of their respective owners.

CONTACT: Neoforma
Rebecca Oles, 408/468-4363 (media)
[e-mail]
Isabelle Trempe, 408/468-4240 (investors)
[e-mail]
or
Novation
Lynn Gentry, 972/581-5255
[e-mail]

[Nebelwandraser]

Also oben steht: Excluding all non-cash and non -recurring charges for the periods, the
net loss was $0.17 per share and $ 0.32 per share for the second quarter.

Bei earnings.com steht estimated EPS 3. quarter: - 0.19 $ .... nach Einschätzung
von drei Analysten. Außerdem steht dort: 2. quarter : - 0.32 $; das steht ja auch im Artikel.

[RudiDutschke]

@Nebelwandraser: Danke für die Erklärung.
Soviel also zu in- bzw. excluding all non-cash.